WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that its presentation at the Canaccord Genuity 31st Annual Growth Conference at 2:00 pm ET on August 11, 2011 will be webcast live.
